Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac + thiocolchicoside injection for acute low back pain
2015-002476-24Phase 3Completed
- Sponsor
- Epifarma
- Start
- Jul 2015
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diclofenac, thiocolchicoside and Dclonom-TH in lumbodynia (LBP) (2 arms), sponsored by Epifarma. Primary endpoint: Primary efficacy endpoint. Started Jul 2015; status: completed.
02
Drugs
diclofenacthiocolchicosideDclonom-TH
03
Conditions
lumbodynia (LBP)
Beyond the preview
Go deeper on 2015-002476-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002476-24.